Experience with tigecyclin at the Department of Infectious, Parasitic and Tropical Diseases of University Hospital Bulovka

Abstract

The article summarizes experience with the use of tigecyclin in two intensive care patients with infections due to multi-resistant strains of Staphylococcus aureus, Enterococcus faecium a Escherichia coli.

Keywords

• tigecyclin
• MRSA
• ESBL resistence
• intensive care